Enveric Biosciences Files 8-K for Material Agreement
Ticker: ENVB · Form: 8-K · Filed: Mar 11, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $1.41 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-statements, 8-k
Related Tickers: ENVB
TL;DR
Enveric Bio (ENVB) filed an 8-K for a new material agreement. Keep an eye on this.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on March 11, 2024, reporting an entry into a material definitive agreement and financial statements. The filing date for the report is March 8, 2024. The company is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This 8-K filing indicates a significant new agreement for Enveric Biosciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the details within the filing will determine the actual risk level.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- March 8, 2024 (date) — Date of earliest event reported
- March 11, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- Naples, FL (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement Enveric Biosciences entered into?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in the summary information.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 8, 2024.
What is Enveric Biosciences' state of incorporation?
Enveric Biosciences, Inc. is incorporated in Delaware.
Where are Enveric Biosciences' principal executive offices located?
The principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What other items are reported in this 8-K filing besides the material agreement?
In addition to the material definitive agreement, the filing also includes 'Financial Statements and Exhibits'.
Filing Stats: 755 words · 3 min read · ~3 pages · Grade level 10.1 · Accepted 2024-03-11 08:00:36
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
- $1.41 — conducted at a deemed offering price of $1.41 per share. The Purchase Agreement con
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex5-1.htm (EX-5.1) — 24KB
- ex10-1.htm (EX-10.1) — 102KB
- ex5-1_001.jpg (GRAPHIC) — 8KB
- ex5-1_002.jpg (GRAPHIC) — 31KB
- ex5-1_003.jpg (GRAPHIC) — 18KB
- ex5-1_004.jpg (GRAPHIC) — 12KB
- ex5-1_005.jpg (GRAPHIC) — 6KB
- 0001493152-24-009485.txt ( ) — 473KB
- envb-20240308.xsd (EX-101.SCH) — 3KB
- envb-20240308_lab.xml (EX-101.LAB) — 33KB
- envb-20240308_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 11, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer